Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001193125-25-283141·Evommune, Inc.
Schedule 13D ownership disclosure
Evommune Inc
Common Stock, $0.0001 par value per share · CUSIP: 30054Y107
Event date: 2025-11-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- LSP 7 Cooperatieve U.A.Reported CIK 0001876264
Shares: 4,929,633 · Class: 15.7%
- LSP 7 Management B.V.
Shares: 4,929,633 · Class: 15.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-283141
- Form type
- SCHEDULE 13D
- Filer
- Evommune, Inc.
- CIK
- CIK 2044725
- Filed
- Nov 14, 2025
- Reporting period
- Nov 07, 2025
- Description
- Schedule 13D beneficial ownership